FVFRX
Price
$64.16
Change
+$0.98 (+1.55%)
Updated
Jun 2 closing price
Net Assets
4.08B
VISVX
Price
$56.60
Change
+$0.48 (+0.86%)
Updated
Jun 2 closing price
Net Assets
64.9B
Interact to see
Advertisement

FVFRX vs VISVX

Header iconFVFRX vs VISVX Comparison
Open Charts FVFRX vs VISVXBanner chart's image
FVFRX vs VISVX Comparison Chart in %
View a ticker or compare two or three
VS
FVFRX vs. VISVX commentary
Jun 04, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FVFRX is a Buy and VISVX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VISVX has more cash in the bank: 64.9B vs. FVFRX (4.08B). VISVX pays higher dividends than FVFRX: VISVX (1.65) vs FVFRX (0.65). FVFRX was incepted earlier than VISVX: FVFRX (24 years) vs VISVX (28 years). FVFRX (1.23) is less costly to investors than VISVX (0.19). FVFRX is a more actively managed with annual turnover of: 52.73 vs. VISVX (25.00). VISVX has a lower initial minimum investment than FVFRX: VISVX (0) vs FVFRX (1000). VISVX annual gain was more profitable for investors over the last year : 24.89 vs. FVFRX (22.61). VISVX return over 5 years is better than : 34.36 vs. FVFRX (2.83).
FVFRXVISVXFVFRX / VISVX
Total Expense Ratio1.220.19642%
Annual Report Gross Expense Ratio1.230.19647%
Fund Existence24 years28 years-
Gain YTD15.18710.611143%
Front LoadN/AN/A-
Min. Initial Investment10000-
Min. Initial Investment IRAN/AN/A-
Net Assets4.08B64.9B6%
Annual Yield % from dividends0.651.6540%
Returns for 1 year22.6124.8991%
Returns for 3 years29.5949.8059%
Returns for 5 years2.8334.368%
Returns for 10 years35.53130.3027%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RBC578.3412.20
+2.15%
RBC Bearings
AWR77.280.88
+1.15%
American States Water Company
FEED0.910.01
+0.62%
ENvue Medical Inc
CSV39.24-1.27
-3.14%
Carriage Services
ONCY0.93-0.13
-12.49%
Oncolytics Biotech